A pan-cancer study of the role of lysine specific demethylase 1 (LSD1) in human cancers
Authors:
Preprint
- 13 September 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Objectives: To conduct a pan-cancer analysis of a relationship between LSD1 and cancer. Setting: Although increasing evidence from cell- or animal-based research supports the existence of a relationship between LSD1 and cancer, there is no pan-cancer analysis. Data sources: Databases, including TCGA, and GEO. Results: On the basis of the TCGA and GEO datasets, we first found that LSD1 may contribute to tumorigenesis across 34 tumor types. LSD1 is expressed in most cancers at a higher level than in normal tissues, and there are distinguishable differences between the LSD1 expression and prognosis of patients. We found that the phosphorylation level of S166 is highly expressed in several tumors, including breast cancer, uterine corpus endometrial carcinoma and lung adenocarcinoma. There was an association between the expression of LSD1 and the infiltration of cancer-associated fibroblasts in BRCA, CESC, ESCA, HNSC, KIRC, LUAD, LUSC, PAAD and PCPG. In addition, RNA transport, mRNA surveillance pathways, and spliceosome -associated functions are also involved in the molecular mechanisms of LSD1. Conclusions: This pan-cancer study provides a fairly comprehensive description of the oncogenic roles of LSD1 in a wide variety of tumors.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cellsScientific Reports, 2017
- Advances Toward Lsd1 Inhibitors for Cancer TherapyFuture Medicinal Chemistry, 2017
- Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell diseaseExperimental Hematology, 2017
- The Gene Expression Omnibus Database2016
- LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP InhibitionPLOS ONE, 2015
- jvenn: an interactive Venn diagram viewerBMC Bioinformatics, 2014
- LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic processCancer Letters, 2014
- A pan-cancer proteomic perspective on The Cancer Genome AtlasNature Communications, 2014
- Regulation of LSD1 Histone Demethylase Activity by Its Associated FactorsMolecular Cell, 2005
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005